PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
29184140-7	2017	RhoGAP depletion mimicked these MTI-mediated processes.	CHEMBL473929	32-35	Rho GTPase activating protein 1	Homo sapiens	0-6
19154728-6	2009	When cell lysate was treated with and without MTI, tacrolimus and FKBP12, FKBP12 could increase calcineurin inhibition by tacrolimus and reverse the MTI antagonism for both MTIs.	CHEMBL473929	46-49	FKBP prolyl isomerase 1A pseudogene 2	Homo sapiens	74-80
19154728-6	2009	When cell lysate was treated with and without MTI, tacrolimus and FKBP12, FKBP12 could increase calcineurin inhibition by tacrolimus and reverse the MTI antagonism for both MTIs.	CHEMBL473929	149-152	FKBP prolyl isomerase 1A pseudogene 2	Homo sapiens	66-72
19154728-6	2009	When cell lysate was treated with and without MTI, tacrolimus and FKBP12, FKBP12 could increase calcineurin inhibition by tacrolimus and reverse the MTI antagonism for both MTIs.	CHEMBL473929	149-152	FKBP prolyl isomerase 1A pseudogene 2	Homo sapiens	74-80
17942929-8	2007	TSLP also partially reverses the effects of MTI on proliferation, apoptosis, and ribosomal protein S6 and 4E-BP1 phosphorylation in cell lines, with similar biological effects seen in some primary human lymphoblast samples.	CHEMBL473929	44-47	thymic stromal lymphopoietin	Homo sapiens	0-4
17942929-10	2007	These findings suggest that IL-7Ralpha chain is responsible for transducing the survival signal that overcomes MTI-mediated growth inhibition in pre-B ALL.	CHEMBL473929	111-114	interleukin 7 receptor	Homo sapiens	28-38
16501580-10	2006	reduced by 50% of the maximum possible efficacy (MPE) mechanical allodynia induced by MTI in FAAH(+/+)mice (von Frey filament measurement) 30 min after dosing, but was without effect in FAAH(-/-) mice.	CHEMBL473929	86-89	fatty acid amide hydrolase	Mus musculus	93-97
27688725-9	2016	Routine analysis of mTOR activity could be performed to select patients that may potentially benefit from mTOR inhibitors (MTI) treatment.	CHEMBL473929	123-126	mechanistic target of rapamycin kinase	Homo sapiens	20-24
27688725-9	2016	Routine analysis of mTOR activity could be performed to select patients that may potentially benefit from mTOR inhibitors (MTI) treatment.	CHEMBL473929	123-126	mechanistic target of rapamycin kinase	Homo sapiens	106-110